Investing
Top Analyst Upgrades (AGN, CHU, ENDP, FLR, GD, LMT, MDZ, NETL, NUVA, SGR)
Published:
These are the top pre-market analyst upgrades and positive research calls we have seen from Wall Street this Tuesday morning:
Allergan (AGN) Raised to Overweight at Thomas Weisel.
China Unicom (CHU) Raised to Buy at UBS.
Endo Pharmaceuticals (ENDP) Started as Overweight at Thomas Weisel.
Fluor (FLR) Started as Outperform at Baird.
General Dynamics (GD) Started as Outperform at Morgan Keegan.
Lockheed Martin (LMT) Started as Outperform at Morgan Keegan.
MDS Inc. (MDZ) Raised to Buy at Jefferies.
NetLogic (NETL) Raised to Buy at Piper Jaffray.
Nuvasive (NUVA) Raised to Buy at Needham.
Shaw Group (SGR) Started as Outperform at Baird.
JON C. OGG
Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.